Published in Gene Therapy Weekly, July 25th, 2002
Pancreatic cancer is one of the disease's deadliest forms. According to estimates from the American Cancer Society, approximately 30,000 people in the U.S. will be diagnosed with pancreatic cancer in the year 2002, and nearly 30,000 people will die from it. University of California at Irvine researchers predict FGFRs may be important in suicide gene therapies used alone or in combination with other treatment modalities for treating PDAC. Such therapies have the potential to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.